Your browser doesn't support javascript.
loading
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.
Provez, Lien; Putteman, Tom; Landfors, Mattias; Roels, Juliette; Reunes, Lindy; T'Sas, Sara; Van Loocke, Wouter; Lintermans, Béatrice; De Coninck, Stien; Thenoz, Morgan; Sleeckx, Wouter; Mackowska-Maslak, Natalia; Taghon, Tom; Mansour, Marc R; Farah, Nadine; Norga, Koen; Vandenberghe, Peter; Kotecha, Rishi S; Goossens, Steven; Degerman, Sofie; De Smedt, Renate; Van Vlierberghe, Pieter.
Afiliación
  • Provez L; Normal and Malignant Hematopoiesis Laboratory, Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Putteman T; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Landfors M; Taghon Laboratory, Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium.
  • Roels J; Department of Medical Biosciences, Umeå University, 90185 Umeå, Sweden.
  • Reunes L; Normal and Malignant Hematopoiesis Laboratory, Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • T'Sas S; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Van Loocke W; Taghon Laboratory, Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium.
  • Lintermans B; Normal and Malignant Hematopoiesis Laboratory, Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • De Coninck S; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Thenoz M; Normal and Malignant Hematopoiesis Laboratory, Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Sleeckx W; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Mackowska-Maslak N; Unit for Translational Research in Oncology, Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium.
  • Taghon T; Normal and Malignant Hematopoiesis Laboratory, Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Mansour MR; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Farah N; Normal and Malignant Hematopoiesis Laboratory, Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Norga K; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Vandenberghe P; Normal and Malignant Hematopoiesis Laboratory, Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Kotecha RS; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Goossens S; Normal and Malignant Hematopoiesis Laboratory, Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Degerman S; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • De Smedt R; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium.
  • Van Vlierberghe P; Unit for Translational Research in Oncology, Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium.
Cancers (Basel) ; 15(3)2023 Jan 20.
Article en En | MEDLINE | ID: mdl-36765607
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Bélgica